Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma.
Peiró G, Ortiz-Martínez F, Gallardo A, Pérez-Balaguer A, Sánchez-Payá J, Ponce JJ, Tibau A, López-Vilaro L, Escuin D, Adrover E, Barnadas A, Lerma E.
Peiró G, et al. Among authors: escuin d.
Br J Cancer. 2014 Aug 12;111(4):689-95. doi: 10.1038/bjc.2014.327. Epub 2014 Jun 17.
Br J Cancer. 2014.
PMID: 24937674
Free PMC article.